691
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Hospitalizations associated with malignant neoplasia and in situ carcinoma in the anus and penis in men and women during a 5-year period (2009–2013) in Spain: An epidemiological study

, , &
Pages 2292-2299 | Received 04 Jan 2017, Accepted 25 Jun 2017, Published online: 18 Oct 2017

References

  • Plummer M , de Martel C , Vignat J , Ferlay J , Bray F , Franceschi S. Global burden of cancers attribuitable to infections in 2012: a synthetic analysis. Lancet Global Health 2016; 4:e609-16; PMID:27470177
  • Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Spain. Summary Report 7 October 2016. http://www.hpvcentre.net/statistics/reports/ESP.pdf. (Accessed 28 October 2016).
  • Johnson LG , Madeleine MM , Newcomer LM , Schwartz SM , Daling JR . Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101:281-8; PMID:15241824
  • Nielsen A , Munk C , Kjaer SK . Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer 2012; 130:1168-73; PMID:21469144
  • Ventimiglia E, Horenblas S, Muneer A, Salonia A. Human Papillomavirus Infection and Vaccination in males. European Urology Focus 2016; 2(4): 355-362. https://doi.org/10.1016/j.euf.2016.08.012
  • Documento de Consenso de Sociedades Científicas Españolas: vacunación frente al virus del papilloma humano 2011. http://vacunasaep.org/sites/vacunasaep.org/files/VPH_Consenso_Sociedades_2011.pdf (Accessed 25 August 2016).
  • Sudenga S , Ingles D , Pierce Campbell CM , Lin H , Fulp WJ , Messina JL , Stoler MH , Abrahamsen M , Villa LL , Lazcano-Ponce E , et al. Genital Human Papillomavirus infection progression to external genital lesions: the HIM study. European Urology 2015, 69(1):166-173; PMID:26051441
  • Harwitg S, Baldauf JJ, Dominiak-Felden G, Simondon F, Alemany L, de Sanjose S, Castellsague X. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Research 2015; 1:90-100. http://www.sciencedirect.com/science/article/pii/S2405852115000099
  • Alemany L , Saunier M , Alvarado-Cabrero I , Quirós B , Salmeron J , Shin H , Pirog EC , Guimerà N , Hernandez-Suarez G , Felix A , et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 2015, 136:98-107; PMID:24817381
  • Serrano B , de Sanjosé S , Tous S , Quiros B , Muñoz N , Bosch X , Alemany L . Human Papillomavirus genotype attribution for HPVs 6,11,16,18,31,33,45,52 and 58 in female anogenital lesions. European J Cancer 2015, 51(13):1732-41; PMID:26121913
  • Alemany L , Cubilla A , Halec G , Kasamatsu E , Quirós B , Masferrer E , Tous S , Lloveras B , Hernández-Suarez G , Lonsdale R , et al. Role of Human Papillomavirus in Penile Carcinomas worldwide. European Urology 2016, 69 (5):953-961; PMID:26762611; https://doi.org/10.1016/j.eururo.2015.12.007
  • Gil-Prieto R , Viguera Ester P , Alvaro-Meca A , San Martin Rodriguez M , Gil de Miguel A . The burden of hospitalizations for anus and penis neoplasm in Spain (1997-2008). Hum Vaccines Immunotherapeutics 2012; 8(2):201-207; PMID:22426377; https://doi.org/10.4161/hv.18388
  • Pitisuttithum P , Velicer C , Luxembourg A . 9-valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV. Expert Rev Vaccines 2015; 14 (11):1405-1419; PMID:26366475; https://doi.org/10.1586/14760584.2015.1089174
  • De Sousa ID , Vidal FC , Branco Vidal JP , de Mello GC , do Desterro Soares Brandão Nascimento M , Brito LM . Prevalence of human papillomavirus in penile malignant tumors: viral genotyping and clinical aspects. BMC Urol 2015; 15:13; PMID:25887354; https://doi.org/10.1186/s12894-015-0007-8
  • Miralles-Guri C , Bruni L , Cubilla AL , Castellsagué X , Bosch FX , de Sanjosé S . Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009; 62(10):870-878; PMID:19706632; https://doi.org/10.1136/jcp.2008.063149
  • Gil A , San-Martín M , Gil R , Hernández V , Ribes J , González A . Burden of hospital admissions for cervical cancer in Spain during 1999-2002. Hum Vaccin 2007; 3:276-80; PMID:17938579; https://doi.org/10.4161/hv.4875
  • Gil-Prieto R , Pascual-Garcia R , Walter S , Álvaro-Meca A , Gil-de-Miguel A . Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study . Hum Vaccines Immunotherapy 2016; 12(7):1900-5
  • Keeping ST , Tempest MJ , Stephens SJ , Carroll SM , Nugent KP , O´Dwyer ST . The cost of anal cancer in England: retrospective hospital data analysis and Markov model. BMC Public Health 2014, 14: 1123; PMID:25361522; https://doi.org/10.1186/1471-2458-14-1123
  • Islami F , Ferlay J , Lortet-Tieulent J , Bray F , Jemal A . International trends in anal cancer incidence rates. Int J Epidemiol 2016, 1-15; PMID:27433568
  • Stanley M . HPV vaccination in boys and men. Human Vaccines Immunotherapeutics 2014, 10(7): 1-3; PMID:24832715; https://doi.org/10.4161/hv.29138
  • Giuliano AR , Kreimer AR , de Sanjose S . The beginning of the end: vaccine prevention of HPV driven cancers. J Natl Cancer Institute 2015, 107(6):djv128; PMID:25911509; https://doi.org/10.1093/jnci/djv128
  • Giuliano AR , Palefsky JM , Goldstone S , Moreira ED, Jr , Penny ME , Aranda C , Vardas E , Moi H , Jessen H , Hillman R , et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364(5):401-11; PMID:21288094; https://doi.org/10.1056/NEJMoa0909537
  • Palefsky JM , Giuliano AR , Goldstone S , Moreira ED, Jr , Aranda C , Jessen H , Hillman R , Ferris D , Coutlee F , Stoler MH , et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365(17):1576-85; PMID:22029979; https://doi.org/10.1056/NEJMoa1010971
  • Castellsague X , Giuliano AR , Goldstone S , Guevara A , Mogensen O , Palefsky JM , Group T , Shields C , Liu K , Maansson R , et al. Immunogenicity and safety of the 9-valent HPV vaccine in men. Vaccine 2015; 33(48):6892-6901; PMID:26144901; https://doi.org/10.1016/j.vaccine.2015.06.088
  • Van Damme P , Meijer C , Kieninger D , Schuyleman A , Thomas S , Luxembourg A , Baudin M . A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine 2016; 34(35):4205-12; PMID:27354258; https://doi.org/10.1016/j.vaccine.2016.06.056
  • Audisio RA , Icardi G , Isodori AM , Liverani CA , Lombardi A , Mariani L , Mennini FS , Mitchell DA , Peracino A , Pecorelli S , et al. Public health Value of universal HPV vaccination. Crit Rev Oncol Hematol 2016; 97:157-67; PMID:26346895; https://doi.org/10.1016/j.critrevonc.2015.07.015
  • Piano Nazionale Prevenzione Vaccinale PNPV 2016-2018. http://www.quotidianosanita.it/allegati/allegato1955037.pdf (Accessed October 2016)
  • Newman P , Lacombe-Duncan A . Human Papillomavirus vaccination for men: advancing policy and practice. Future Virol 2014, 9(12):1033-1047; https://doi.org/10.2217/fvl.14.91
  • Consejo Interterritorial del sistema nacional de salud. Acuerdo no: 655 Pleno: 10 de octubre de 2007 Acta no: 79. http://www.msps.es/organizacion/consejoInterterri/docs/655.pdf. (Accessed 25 August 2016).
  • Ministerio de Sanidad, Servicios Sociales e Igualdad [Web]. Calendarios de Comunidades y Ciudades Autónomas. https://www.msssi.gob.es/ciudadanos/proteccionSalud/vacunaciones/docs/CalendarioVacunacion2016.pdf (Accessed 29 October 2016 ).
  • HPV vaccination coverage rates. http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/CoberturasVacunacion/Tabla8.pdf (Accessed 30 October 2016 ).
  • Peiro S , Librero J . Evaluación de la calidad a partir del conjunto mínimo de datos básicos al alta hospitalaria. Rev Neurol 1999; 29:651-61; PMID:10599116
  • Huff L, Bogdan G, Burke K, Hayes E, Perry W, Graham L, Lentzner H. Using hospital discharge data for disease surveillance. Public Health Rep 1996; 111(1):78. PMID:8610197
  • Penberthy L , McClish D , Pugh A , Smith W , Manning C , Retchin S . Using hospital discharge files to enhance cancer surveillance. Am J Epidemiol 2003; 158:27-34; PMID:12835284; https://doi.org/10.1093/aje/kwg108
  • Ministerio de Sanidad, Servicios Sociales e Igualdad. CLASIFICACIÓN INTERNACIONAL DE ENFERMEDADES 10.a REVISIÓN, MODIFICACIÓN CLÍNICA. EDICIÓN ESPAÑOLA. https://eciemaps.mspsi.es/ecieMaps/browser/index_9_mc.html#search=233.3&flags=111100&flagsLT=11111111&searchId=1471948733037&indiceAlfabetico=&listaTabular=233.3&expand=0&clasification=&version (Accessed 29 October 2016).
  • Rivero Cuadrado A . Análisis y desarrollo de los GDR en el Sistema Nacional de Salud. http://www.msssi.gob.es/estadEstudios/estadisticas/docs/analisis.pdf. (Accessed 29 October 2016 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.